Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease

Journal of Vascular Surgery

Volumn 58, Issue 6, 2013, Pages 1525-1531

  Vartanian, Shant M ^a   Johnston, Paul C ^b   Walker, Joy P ^a   Runge, Sara J ^a   Eichler, Charles M ^a   Reilly, Linda M ^a   Hiramoto, Jade S ^a   Conte, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Departments of Internal Medicine and Metabolic Surgical Weight Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AGED; AMPUTATION; ARTERY OCCLUSION; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; ENDOVASCULAR SURGERY; FEMALE; FEMOROPOPLITEAL BYPASS; FEMOROPOPLITEAL OCCLUSIVE DISEASE; FOLLOW UP; GRAFT FAILURE; HEART ARRHYTHMIA; HUMAN; KIDNEY FAILURE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STENOSIS; STENT; STENT THROMBOSIS; TREATMENT INDICATION;

AGED; ANGIOGRAPHY; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; COLORADO; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEG; MALE; POPLITEAL ARTERY; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; STENTS; VASCULAR PATENCY;

EID: 84888373268     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.05.094     Document Type: Article

References (17)

1. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 e654
2. P.P. Goodney, A.W. Beck, J. Nagle, H.G. Welch, and R.M. Zwolak National trends in lower extremity bypass surgery, endovascular interventions, and major amputations J Vasc Surg 50 2009 54 60
3. P.H. Lin, S.M. Weakley, and P. Kougias How to interpret data from the superficial femoral artery stenting trials and registries Semin Vasc Surg 23 2010 38 47
4. J.R. Laird, B.T. Katzen, D. Scheinert, J. Lammer, J. Carpenter, and M. Buchbinder Nitinol stent implantation vs balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial J Endovasc Ther 19 2012 1 9
5. M. Schillinger, S. Sabeti, C. Loewe, P. Dick, J. Amighi, and W. Mlekusch Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
6. H. Krankenberg, M. Schluter, H.J. Steinkamp, K. Burgelin, D. Scheinert, and K.L. Schulte Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) Circulation 116 2007 285 292
7. Y.S. Alimi, Z. Hakam, O. Hartung, M. Boufi, P. Barthelemy, and K. Aissi Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency? Eur J Vasc Endovasc Surg 5 2008 346 352
8. R.R. Saxon, J.M. Coffman, J.M. Gooding, and D.J. Ponec Long-term patency and clinical outcome of the Viabahn stent graft for femoropopliteal artery obstructions J Vasc Interv Radiol 18 2007 1341 1349 quiz 1350
9. J. Kedora, S. Hohmann, W. Garrett, C. Munschaur, B. Theune, and D. Gable Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease J Vasc Surg 45 2007 10 16 discussion: 16
10. P.J. Geraghty Covered stenting of the superficial femoral artery using the Viabahn stent-graft Perspect Vasc Surg Endovasc Ther 18 2006 39 43
11. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, and S. Ahn Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
12. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G. Fowkes Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg 33 Suppl 1 2007 S1 75
13. M.S. Conte, P.J. Geraghty, A.W. Bradbury, N.D. Hevelone, S.R. Lipsitz, and G.L. Moneta Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia J Vasc Surg 50 2009 1462 1473 e1
14. D.M. Ihnat, and J.L. Mills Sr. Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes J Vasc Surg 52 3 Suppl 2010 92S 95S
15. M.G. Davies, W.E. Saad, E.K. Peden, I.T. Mohiuddin, J.J. Naoum, and A.B. Lumsden Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss J Vasc Surg 48 2008 619 625 discussion: 625-6
16. B.G. DeRubertis, M. Pierce, R.A. Chaer, S.J. Rhee, R. Benjeloun, and E.J. Ryer Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention J Vasc Surg 46 2007 709 716
17. P.C. Johnston, S.M. Vartanian, S.J. Runge, J.S. Hiramoto, C.M. Eichler, and C.D. Owens Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease J Vasc Surg 56 2012 998 1006